PLIANT THERAPEUTICS INC. - COMMON STOCK

Pliant Therapeutics Reports Positive Interim Results from Phase 2a PET Imaging Clinical Trial in Patients with Idiopathic Pulmonary Fibrosis

07 Sep 2021 06:00:01 By Nasdaq GlobeNewswire

Pliant Therapeutics Announces Webcast to Present Interim Clinical Data from Ongoing Phase 2a PET Trial of PLN-74809 in Patients with Idiopathic Pulmonary Fibrosis

03 Sep 2021 15:10:00 By Nasdaq GlobeNewswire

Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2021 Financial Results

09 Aug 2021 15:05:02 By Nasdaq GlobeNewswire

Pliant Therapeutics to Participate in the BTIG Biotechnology Conference

03 Aug 2021 07:00:01 By Nasdaq GlobeNewswire

Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2021 Financial Results

10 May 2021 15:21:16 By Nasdaq GlobeNewswire

Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference

05 May 2021 07:05:00 By Nasdaq GlobeNewswire

Pliant Therapeutics to Participate in Annual Needham Virtual Healthcare Conference

05 Apr 2021 07:00:00 By Nasdaq GlobeNewswire

Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results

16 Mar 2021 15:05:00 By Nasdaq GlobeNewswire

Pliant Therapeutics Announces Successful Completion of PLN-1474 Phase 1 Study and Development Transition to Global Pharmaceutical Partner

16 Mar 2021 07:00:01 By Nasdaq GlobeNewswire

Pliant Therapeutics to Participate in Upcoming Virtual Investor Events

18 Feb 2021 07:30:00 By Nasdaq GlobeNewswire

Pliant Therapeutics Announces Appointment of David Pyott to Board of Directors

12 Jan 2021 07:00:01 By Nasdaq GlobeNewswire

Pliant Therapeutics Announces Appointment of Gregory P. Cosgrove, M.D., FCCP, as Vice President of Clinical Development, IPF

04 Jan 2021 07:00:01 By Nasdaq GlobeNewswire